Atrial fibrillation (Afib) is the most common sustained heart rhythm condition in the world, affecting an estimated 37 million people globally, a number expected to more than double by 2050 as populations age. Yet two people with the same diagnosis can have very different experiences of the condition, different symptoms, different triggers, different risks, and different responses to the same treatment. This is not unusual or unexplained: it reflects genuine differences in biology, lifestyle, and circumstance. And it matters, because it means that a one-size-fits-all approach to Afib care often falls short.
Atrial fibrillation (Afib) is the most common sustained heart rhythm condition worldwide. As populations age, more and more people are expected to live with Afib in the coming decades.
But Afib does not feel the same for everyone. Some people clearly notice when their heart rhythm changes, while others hardly feel it at all. Some begin to recognize patterns over time, such as the influence of stress, poor sleep, infections, alcohol, or certain foods. Others are still searching for what may play a role in their own situation.
This variety is part of what makes Afib so personal. Symptoms, triggers, risks, and responses to treatment can vary from person to person. That is why personalized support for Afib is so important: not to replace medical care, but to help people better understand their own experiences and make more informed choices together with their healthcare team.
Key insights
-
Afib is a heterogeneous condition: symptoms, triggers, risk, and response to treatment vary substantially between individuals depending on age, sex, other health conditions, and lifestyle.
-
Women develop Afib later than men but tend to have more severe symptoms and higher stroke risk and are less likely to be referred for advanced treatments, a gap that evidence-based care needs to address.
-
The EAST-AFNET 4 trial showed that early efforts to restore and maintain normal rhythm reduced major cardiovascular events by 21%, with the greatest benefit in younger, otherwise healthier individuals.
-
The 2024 ESC ABC pathway provides a structured, person-centered framework covering stroke prevention, symptom management, and treatment of underlying health conditions.
-
Weight loss of at least 10% significantly reduces Afib burden and is given the highest level of recommendation (Class I) in the 2024 ESC Guidelines for people with Afib who are overweight.
-
Stroke risk is not fixed, it changes over time and should be reassessed regularly as health conditions evolve.
-
Tracking your own data over time is one of the most practical tools for personalizing support and enabling more representative research.
The range of Afib
Afib is often classified into types based on how long episodes last. Paroxysmal Afib refers to episodes that come and go, usually stopping on their own within seven days. Persistent Afib lasts longer than seven days and may need treatment to restore a normal rhythm. Long-standing persistent Afib means that Afib has been continuous for more than twelve months. Permanent Afib is when the person and their doctor have agreed that restoring a normal rhythm is no longer the goal, and the focus is on managing the heart rate, reducing risks and supporting quality of life.
But the type of Afib is only one part of what makes each person's experience unique. What triggers Afib, what makes it worse, and which treatments work or self-management strategies help most can vary from person to person. . Age, sex, other health conditions, body weight, and lifestyle and daily circumstances may all play a role.
Why Afib varies so much between people
Sex differences in Afib
Men and women do not always experience Afib in the same way. On average, women tend to develop Afib later in life than men, but they may experience more symptoms and a greater impact on daily life and wellbeing.
These differences are likely shaped by several factors. Biology, hormones, age, other health conditions, and body size may all influence how Afib develops and how it is felt. There may also be differences in how Afib is recognized and treated. Studies suggest that women with Afib are sometimes referred later, or less often, for rhythm-control treatments such as ablation, even when these options could be considered.
Recognizing these differences matters. It can help people ask better questions, support more personalized decisions, and ensure that Afib experiences are taken seriously, regardless of sex.
How age changes the picture
Afib becomes much more common as people get older. This is partly because the heart changes over time. The atrial tissue may gradually become less flexible, electrical signals may travel differently, and small areas of scarring can develop. Together, these changes can create an environment in which Afib is more likely to occur or continue.
Age also often comes with other health conditions, such as high blood pressure, heart failure, diabetes, kidney disease, or sleep problems. These can increase the chance of Afib and make treatment decisions more personal.
This is why managing Afib in an older person with several other health concerns may require a different balance of priorities than in someone younger who is otherwise healthy. In both situations, the goal is the same: to find an approach that fits the person, not only the rhythm.
Other health conditions that drive Afib
Afib often does not occur on its own. Many people living with Afib also have other health conditions that can affect the heart and make Afib more likely to occur, continue, or return.
Heart failure, where the heart does not pump as effectively as it should, can increase pressure inside the heart and contribute to changes in the atrial tissue. High blood pressure can place extra strain on the heart over time. Obesity is linked to enlargement of the atria, fat around the heart, and low-grade inflammation, all of which may make Afib more difficult to manage. Obstructive sleep apnea, where breathing repeatedly stops and starts during sleep, can lead to changes in oxygen levels and stress responses during the night, placing additional strain on the heart.
This is why addressing underlying health conditions is now seen as an essential part of personalized support for Afib, not something separate from it.
Evidence that personalized care improves outcomes
Early rhythm control
For a long time, the standard approach to Afib was to focus primarily on controlling the heart rate and preventing stroke, rather than actively trying to restore and maintain a normal rhythm. The EAST-AFNET 4 trial, which enrolled over 2,600 people diagnosed with early Afib within the previous twelve months, challenged this approach. People assigned to early, systematic efforts to restore and maintain a normal rhythm had a 21% lower risk of major cardiovascular events, including cardiovascular death, stroke, and hospitalization for worsening heart failure, over five years, compared with those receiving rate control alone. The benefit was most pronounced in people who were younger and had fewer other health conditions, reinforcing that the right treatment approach depends on the individual.
Stroke risk is not the same for everyone
One of the most serious complications of Afib is stroke. Because the atria do not contract in their usual coordinated way, blood may move more slowly and clots can form. If a clot travels to the brain, it can cause a stroke.
But stroke risk is not the same for everyone. Doctors estimate this risk by looking at factors such as age, heart failure, high blood pressure, diabetes, previous stroke, and vascular disease. In the 2024 ESC Guidelines, this is assessed using a score called CHA₂DS₂-VA. Based on this score, blood-thinning medication is recommended for people at higher risk and may be considered for people at intermediate risk.
Importantly, stroke risk is not fixed. It can change over time as people get older, develop new health conditions, or improve their overall health. That is why stroke risk should be reassessed regularly, rather than calculated once and then forgotten.
Lifestyle changes with strong evidence
For some people, lifestyle changes can make a meaningful difference in Afib. This is especially well studied for weight management in people who are overweight.
In the LEGACY study, 355 people with Afib were followed over several years. Those who achieved and maintained a weight loss of at least 10% had fewer Afib episodes, fewer symptoms, and a greater chance of remaining free from arrhythmia than those who lost less weight or whose weight fluctuated.
The ARREST-AF study also showed that a structured program addressing several risk factors together, including weight, blood pressure, fitness, sleep apnea, diabetes, cholesterol, smoking, and alcohol intake, was linked to better long-term rhythm outcomes after ablation.
These findings show that lifestyle and risk-factor management are not just “extra” advice. For many people with Afib, they can be an important part of personalized support. The 2024 ESC Guidelines recommend weight loss as part of comprehensive risk-factor management for people with Afib who are overweight, with a target of at least 10% body-weight reduction where appropriate.
The AF-CARE framework: a structured approach to personalized support
The 2024 ESC Guidelines organize Afib management around a framework called AF-CARE. This framework helps bring together the main parts of Afib care: managing other health conditions and risk factors, reducing the risk of stroke, improving symptoms through rate or rhythm control, and regularly reassessing the situation over time.
This approach recognizes that Afib is not static. A person’s symptoms, risk factors, health conditions, treatment goals, and daily life can change. What works well at one stage may need to be adjusted later.
The guidelines also emphasize shared decision-making. This means that treatment decisions should not only be based on medical information, but also on what matters to the person living with Afib: their preferences, concerns, lifestyle, and ability to follow a treatment plan. For MyAfib, this is an important message: personalized support begins with understanding the person behind the rhythm.
How MyAfib fits in
Personalized support for Afib starts with better understanding your own experience. A clinic appointment can provide an important medical snapshot, but many aspects of Afib happen in daily life: symptoms, possible triggers, medication use, sleep, stress, activity, lifestyle habits, and heart rhythm patterns over time.
By tracking these experiences in MyAfib, you can build a personal record that may help you recognize patterns and prepare for conversations with your healthcare provider. Over time, this can support more informed discussions about what may influence your Afib and how well your current approach is working for you.
When many people choose to share their experiences for research, these real-world insights can also help scientists better understand why Afib varies so much between people. This may contribute to more personalized approaches in the future, by showing which patterns, needs, and strategies matter most to different groups of people living with Afib.
As always, speak with your healthcare provider before making any changes to your treatment or routine.
